- Home
- SVM vs OCS Comparison
SVM vs OCS Comparison
Compare SVM & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVM | OCS |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Canada | Switzerland |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SVM | OCS |
|---|---|---|
| Price | $8.90 | $20.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $9.00 | ★ $39.57 |
| AVG Volume (30 Days) | ★ 5.7M | 114.7K |
| Earning Date | 02-10-2026 | 11-10-2025 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $323,391,000.00 | $991,999.00 |
| Revenue This Year | $22.28 | $14.53 |
| Revenue Next Year | $32.53 | $691.13 |
| P/E Ratio | $75.24 | ★ N/A |
| Revenue Growth | ★ 33.99 | N/A |
| 52 Week Low | $2.88 | $14.00 |
| 52 Week High | $9.17 | $23.08 |
Technical Indicators
Market Signals| Indicator | SVM | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 66.09 | 54.68 |
| Support Level | $8.37 | $20.18 |
| Resistance Level | $9.17 | $21.33 |
| Average True Range (ATR) | 0.45 | 0.72 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 79.79 | 54.38 |
Price Performance
Historical ComparisonAbout SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.